Zimmer Biomet Holdings (XSWX:ZBH) Other Current Liabilities: CHF814 Mil (As of Mar. 2026)


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
69 GF Score
Price CHF71.00
GF Value CHF97.75
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Other Current Liabilities?

Zimmer Biomet Holdings XSWX:ZBH +2.16% 69 Other Current Liabilities is CHF814 Mil as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF97.75 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings's other current liabilities for the quarter that ended in Mar. 2026 was CHF814 Mil.

Zimmer Biomet Holdings's quarterly other current liabilities declined from Sep. 2025 (CHF1,184 Mil) to Dec. 2025 (CHF304 Mil) but then increased from Dec. 2025 (CHF304 Mil) to Mar. 2026 (CHF814 Mil).

Zimmer Biomet Holdings's annual other current liabilities declined from Dec. 2023 (CHF282 Mil) to Dec. 2024 (CHF280 Mil) but then increased from Dec. 2024 (CHF280 Mil) to Dec. 2025 (CHF304 Mil).

Zimmer Biomet Holdings Other Current Liabilities Related Terms

Zimmer Biomet Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Other Current Liabilities Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 589.90 468.41 282.01 279.61 304.42

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,231.39 1,244.85 1,184.28 304.42 813.52
XSWX:ZBH
69GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of CHF814 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Other Current Liabilities of CHF814 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Zimmer Biomet Holdings.
Is Zimmer Biomet Holdings' Other Current Liabilities too high?
Zimmer Biomet Holdings' current Other Current Liabilities is CHF814 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Other Current Liabilities compare to STE and PEN?
Zimmer Biomet Holdings' Other Current Liabilities of CHF814 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Zimmer Biomet Holdings. Zimmer Biomet Holdings's current Other Current Liabilities is CHF814 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF97.75, compared to a current price of CHF71.00 — trading 27.4% below its estimated fair value. The current Other Current Liabilities is CHF814 Mil. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Other Current Liabilities is CHF814 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF71.00 is trading 27.4% below its estimated GF Value™ of CHF97.75. GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.

Key valuation signals for XSWX:ZBH:

  • Other Current Liabilities: CHF814 Mil
  • GF Value™: CHF97.75 vs. price of CHF71.00 (27.4% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score

Get the complete analysis for XSWX:ZBH

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.00
Price
CHF97.75
GF Value